Castle Hill Capital Partners | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

16,769 results for “Castle Hill Capital Partners”

Trials

View all 9423 →

Not yet recruiting

PACTR201806003389716

Capital Mãe

446 participants

Not yet recruiting

CAPITAL OFFLOAD-SHOCK

456 participants · First posted Aug 11, 2026

Seton Hill University--Personal Empowerment Program

70 participants · First posted Jun 19, 2015

Drugs

View all 330 →

trimethylangelicin (Rare Partners)

DLL3(Molecular Partners)

FAH (Castle Creek Biosciences)

Organizations

View all 209 →

Proximity Capital Partners, LLC

United States

Hull University Teaching Hospitals Nhs Trust

United Kingdom

Castle Creek Biosciences, LLC

United States

News

View all 6807 →

PleoPharma Raises $36M Series B to Advance First-in-Class Cannabis Withdrawal Treatment to Phase 3

Oak Hill Bio to Go Public via SPAC Merger, Secures $175 Million to Advance Rugonersen for Angelman Syndrome Through Phase 3

Bluebird Bio Goes Private in $29M Deal with Carlyle and SK Capital Partners

Page 1 of 1677